Aggarwal S, Gross CM, Kumar S, Dimitropoulou C, Sharma S, Gorshkov BA, Sridhar S, Lu Q, Bogatcheva NV, Jezierska-Drutel AJ et al (2014) Dimethylarginine dimethylaminohydrolase II overexpression attenuates LPS-mediated lung leak in acute lung injury. Am J Respir Cell Mol Biol 50:614–625. https://doi.org/10.1165/rcmb.2013-0193OC
CAS Article PubMed PubMed Central Google Scholar
Allen Institute for Brain Science (2010) Allen Mouse Brain Atlas. http://mouse.brain-map.org/ March 12, 2020.
Altmann KS, Havemeyer A, Beitz E, Clement B (2012) Dimethylarginine-dimethylaminohydrolase-2 (DDAH-2) does not metabolize methylarginines. ChemBioChem 13:2599–2604. https://doi.org/10.1002/cbic.201200499
CAS Article PubMed Google Scholar
Antoniades C, Shirodaria C, Leeson P, Antonopoulos A, Warrick N, Van-Assche T, Cunnington C, Tousoulis D, Pillai R, Ratnatunga C et al (2009) Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis. Eur Heart J 30:1142–1150. https://doi.org/10.1093/eurheartj/ehp061
CAS Article PubMed Google Scholar
Asif M, Soiza RL, McEvoy M, Mangoni AA (2013) Asymmetric dimethylarginine: a possible link between vascular disease and dementia. Curr Alzheimer Res 10:347–356. https://doi.org/10.2174/1567205011310040001
CAS Article PubMed Google Scholar
Ayling LJ, Whitley GSJ, Aplin JD, Cartwright JE (2006) Dimethylarginine dimethylaminohydrolase (DDAH) regulates trophoblast invasion and motility through effects on nitric oxide. Hum Reprodction 21:2530–2537. https://doi.org/10.1093/humrep/del111
Baranyi A, Amouzadeh-Ghadikolai O, Rothenhäusler H-B, Theokas S, Robier C, Baranyi M, Koppitz M, Reicht G, Hlade P, Meinitzer A (2015) Nitric oxide-related biological pathways in patients with major depression. PLoS ONE 10:e0143397–e0143397. https://doi.org/10.1371/journal.pone.0143397
CAS Article PubMed PubMed Central Google Scholar
Boger RH (2005) Asymmetric dimethylarginine (ADMA) and cardiovascular disease: insights from prospective clinical trials. Vasc Med 10(Suppl 1):S19-25
Böhme GA, Bon C, Lemaire M, Reibaud M, Piot O, Stutzmann J-M, Doble A, Blanchard J-C (1993) Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proc Natl Acad Sci 90:9191–9194
Braun D, Schlossmann J, Haen E (2021) Asymmetric dimethylarginine in psychiatric disorders. Psychiatry Res 300:113901. https://doi.org/10.1016/j.psychres.2021.113901
CAS Article PubMed Google Scholar
Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM (2007) Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 8:766–775. https://doi.org/10.1038/nrn2214
CAS Article PubMed Google Scholar
Celik C, Cayci T, Ozdemir B, Akgul EO, Zincir S, Balikci A, Uzun O, Yaman H (2011) Plasma asymmetric dimethylarginine (ADMA) concentrations in patients with first and multiple episode schizophrenia. Psychiatry Res 190:177–180. https://doi.org/10.1016/j.psychres.2011.06.003
CAS Article PubMed Google Scholar
Chen J, Zacharek A, Zhang C, Jiang H, Li Y, Roberts C, Lu M, Kapke A, Chopp M (2005) Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice. J Neurosci 25:2366–2375. https://doi.org/10.1523/JNEUROSCI.5071-04.2005
CAS Article PubMed PubMed Central Google Scholar
Chen S, Li N, Deb-Chatterji M, Dong Q, Kielstein JT, Weissenborn K, Worthmann H (2012) Asymmetric dimethyarginine as marker and mediator in ischemic stroke. Int J Mol Sci 13:15983–16004
Chi J-T, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, Chang DS, Wang Z, Rockson SG, van de Rijn M, Botstein D et al (2003) Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci 100:10623. https://doi.org/10.1073/pnas.1434429100
CAS Article PubMed PubMed Central Google Scholar
Cleuren ACA, van der Ent MA, Jiang H, Hunker KL, Yee A, Siemieniak DR, Molema G, Aird WC, Ganesh SK, Ginsburg D (2019) The in vivo endothelial cell translatome is highly heterogeneous across vascular beds. Proc Natl Acad Sci 116:23618. https://doi.org/10.1073/pnas.1912409116
CAS Article PubMed PubMed Central Google Scholar
Dayal S, Rodionov RN, Arning E, Bottiglieri T, Kimoto M, Murry DJ, Cooke JP, Faraci FM, Lentz SR (2008) Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia. Am J Physiol 295:H816–H825. https://doi.org/10.1152/ajpheart.01348.2007
de Sousa AR, Penalva LO, Marcotte EM, Vogel C (2009) Global signatures of protein and mRNA expression levels. Mol Biosyst 5:1512–1526. https://doi.org/10.1039/b908315d
Dhir A, Kulkarni SK (2011) Nitric oxide and major depression. Nitric Oxide 24:125–131. https://doi.org/10.1016/j.niox.2011.02.002
CAS Article PubMed Google Scholar
D’Mello R, Sand CA, Pezet S, Leiper JM, Gaurilcikaite E, McMahon SB, Dickenson AH, Nandi M (2015) Dimethylarginine dimethylaminohydrolase 1 is involved in spinal nociceptive plasticity. Pain 156:2052–2060. https://doi.org/10.1097/j.pain.0000000000000269
CAS Article PubMed PubMed Central Google Scholar
Dowsett L, Piper S, Slaviero A, Dufton N, Wang Z, Boruc O, Delahaye M, Colman L, Kalk E, Tomlinson J et al (2015) Endothelial dimethylarginine dimethylaminohydrolase 1 is an important regulator of angiogenesis but does not regulate vascular reactivity or hemodynamic homeostasis. Circulation 131:2217–2225. https://doi.org/10.1161/CIRCULATIONAHA.114.015064
CAS Article PubMed Google Scholar
EMBL-EBI (2020) HUGO Gene Nomenclature Commitee. https://www.genenames.org/ September 9, 2020.
Freudenberg F, Alttoa A, Reif A (2015) Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders. Genes Brain Behav 14:46–63. https://doi.org/10.1111/gbb.12193
CAS Article PubMed Google Scholar
Frey D, Braun O, Briand C, Vašák M, Grütter MG (2006) Structure of the mammalian NOS regulator dimethylarginine dimethylaminohydrolase: a basis for the design of specific inhibitors. Structure 14:901–911. https://doi.org/10.1016/j.str.2006.03.006
CAS Article PubMed Google Scholar
Gang Zhang Z, Chopp M, Gautman S, Zaloga C, Lan Zhang R, Schmidt HHHW, Pollack JS, Förstermann U (1994) Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after local cerebral ischemia in rat. Brain Res 654:85–95. https://doi.org/10.1016/0006-8993(94)91574-1
Gatto EM, Riobó NA, Carreras MC, Cherñavsky A, Rubio A, Satz ML, Poderoso JJ (2000) Overexpression of neutrophil neuronal nitric oxide synthase in parkinson’s disease. Nitric Oxide 4:534–539. https://doi.org/10.1006/niox.2000.0288
CAS Article PubMed Google Scholar
Greco R, Ferrigno A, Demartini C, Zanaboni A, Mangione AS, Blandini F, Nappi G, Vairetti M, Tassorelli C (2015) Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine. J Headache Pain 16:560. https://doi.org/10.1186/s10194-015-0560-2
CAS Article PubMed Google Scholar
Gunawardana H, Romero T, Yao N, Heidt S, Mulder A, Elashoff DA, Valenzuela NM (2021) Tissue-specific endothelial cell heterogeneity contributes to unequal inflammatory responses. Sci Rep 11:1949. https://doi.org/10.1038/s41598-020-80102-w
CAS Article PubMed PubMed Central Google Scholar
Hannemann J, Appel D, Seeberger-Steinmeister M, Brüning T, Zummack J, Böger R (2020) Sequence variation in the DDAH1 gene predisposes for delayed cerebral ischemia in subarachnoidal hemorrhage. J Clin Med 9:3900
Hasegawa K, Wakino S, Tatematsu S, Yoshioka K, Homma K, Sugano N, Kimoto M, Hayashi K, Itoh H (2007) Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2. Circ Res 101:e2–e10. https://doi.org/10.1161/circresaha.107.156901
CAS Article PubMed Google Scholar
Hölscher C, McGlinchey L, Anwyl R, Rowan MJ (1996) 7-Nitro indazole, a selective neuronal nitric oxide synthase inhibitor in vivo, impairs spatial learning in the rat. Learn Mem 2:267–278
Hu X, Atzler D, Xu X, Zhang P, Guo H, Lu Z, Fassett J, Schwedhelm E, Boger RH, Bache RJ et al (2011) Dimethylarginine dimethylaminohydrolase-1 is the critical enzyme for degrading the cardiovascular risk factor asymmetrical dimethylarginine. Arterioscler Thromb Vasc Biol 31:1540–1546. https://doi.org/10.1161/atvbaha.110.222638
CAS Article PubMed PubMed Central Google Scholar
Human Protein Atlas (2020) Human Protein Atlas. http://www.proteinatlas.org September 9, 2020.
Izumi Y, Clifford D, Zorumski C (1992) Inhibition of long-term potentiation by NMDA-mediated nitric oxide release. Science 257:1273–1276. https://doi.org/10.1126/science.1519065
CAS Article PubMed Google Scholar
Jambusaria A, Hong Z, Zhang L, Srivastava S, Jana A, Toth PT, Dai Y, Malik AB, Rehman J (2020) Endothelial heterogeneity across distinct vascular beds during homeostasis and inflammation. Elife. https://doi.org/10.7554/eLife.51413
Article PubMed PubMed Central Google Scholar
Kakimoto Y, Akazawa S (1970) Isolation and identification of Ng, Ng- and Ng, N’g-dimethylarginine, Nε-mono-, Di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-δ-hydroxylysine from human urine. J Biol Chem 245:5751–5758
Kirbas S, Kirbas A, Tufekci A, Cumhur Cure M, Cakmak S, Yazici T, Cure E (2016) Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson’s disease. Acta Clin Belg 71:71–75. https://doi.org/10.1080/17843286.2016.1138592
Lambden S, Kelly P, Ahmetaj-Shala B, Wang Z, Lee B, Nandi M, Torondel B, Delahaye M, Dowsett L, Piper S et al (2015) Dimethylarginine dimethylaminohydrolase 2 regulates nitric oxide synthesis and hemodynamics and determines outcome in polymicrobial sepsis. Arteriosc Thromb Vasc Biol 35:1382–1392. https://doi.org/10.1161/ATVBAHA.115.305278
留言 (0)